The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Induction chemotherapy (IC) followed by concomitant radiotherapy and weekly cisplatin (CCRT) versus CCRT alone in patients with locally advanced (LA) nasopharyngeal carcinoma (NPC): Twenty-year follow-up of a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
 
Amanda Psyrri
Honoraria - AstraZeneca; Bristol Myers Squibb Foundation; Merck Serono; Merus; MSD
Consulting or Advisory Role - AstraZeneca; Merck Serono; Merus
Research Funding - Demo Pharmaceutical; Ipsen; MSD (Inst)
Travel, Accommodations, Expenses - Genesis Biotechnology Group; Ipsen
 
Georgios Karakatsoulis
No Relationships to Disclose
 
Kyriaki Papadopoulou
No Relationships to Disclose
 
Elisabeta Ciuleanu
No Relationships to Disclose
 
Tudor Ciuleanu
No Relationships to Disclose
 
Liliana Resiga
No Relationships to Disclose
 
Mattheos Bobos
No Relationships to Disclose
 
Konstantinos Markou
No Relationships to Disclose
 
Epaminondas Samantas
Consulting or Advisory Role - Amgen; AstraZeneca; Genesis Biotechnology Group; Merck Serono; MSD; Roche
 
Dimitrios Krikelis
Employment - Daiichi Sankyo Pharmaceuticals
Leadership - Daiichi Sankyo Pharmaceuticals; Novartis
 
George Fountzilas
Stock and Other Ownership Interests - Daiichi Sankyo; Deciphera (I); FORMYCON; Genprex; Genprex (I); Rafael Holdings
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Amgen (I); Novartis
Speakers' Bureau - AstraZeneca (I); GlaxoSmithKline (I); Lilly (I); Roche (I)
Travel, Accommodations, Expenses - AstraZeneca (I); Genesis Pharmaceuticals (I); K.A.M Oncology/Hematology (I); Pfizer (I)